Cargando…
Uremia does not affect neointima formation in mice
Atherosclerotic cardiovascular disease is a major complication of chronic kidney disease (CKD). CKD leads to uremia, which modulates the phenotype of aortic smooth muscle cells (SMCs). Phenotypic modulation of SMCs plays a key role in accelerating atherosclerosis. We investigated the hypothesis that...
Autores principales: | Aarup, Annemarie, Nielsen, Carsten H., Bisgaard, Line S., Bot, Ilze, El-Ali, Henrik H., Kjaer, Andreas, Nielsen, Lars B., Pedersen, Tanja X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529519/ https://www.ncbi.nlm.nih.gov/pubmed/28747676 http://dx.doi.org/10.1038/s41598-017-06816-6 |
Ejemplares similares
-
Uremia increases QRS duration after β‐adrenergic stimulation in mice
por: Thomsen, Morten B., et al.
Publicado: (2018) -
ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model
por: Simolin, Mikko A, et al.
Publicado: (2009) -
Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification
por: Gravesen, Eva, et al.
Publicado: (2018) -
Uremia
por: Low, J. H.
Publicado: (1883) -
Influence of valsartan-eluting stent on neointima formation
por: Guihua, Li, et al.
Publicado: (2010)